News

Horizon Europe Health Calls: €21.6M awarded with 60% overall success rate!

This week the results from the April 2024 round of the Horizon Health Calls were released.

Congratulations to our inspiring clients!

We are thrilled to announce that across the Horizon Health April Calls we supported our clients in securing €21.6M with a whopping 60% overall success rate. We are immensely proud to help bring these impactful projects to life, under the topics of healthcare access for vulnerable people, reducing disease burden, and pandemic preparedness. Congratulations to our inspiring clients!

Beating notoriously low success rates

Horizon Europe Health Calls have notoriously low success rates – in the calls where these projects were awarded, the success rates were 3%, 5%, and 17%, respectively. Well done to our colleagues who made this 60% success rate happen. What an incredible collaboration!

Horizon Europe Health April 2024 calls

The winning projects fall under the following calls:

HORIZON-HLTH-2024-CARE-04-04-two-stage: Access to health and care services for people in vulnerable situations

Read more 

HORIZON-HLTH-2024-DISEASE-03-14-two-stage: Tackling high-burden for patients, under-researched medical conditions

Read more 

HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential

Read more

 


 

Further reading

Learn more about Horizon Europe

Download our Horizon Europe general guide

 


 

About Catalyze

Catalyze is an innovation consultancy committed to accelerating innovations that have a positive impact on people and planet. We deploy a unique combination of scientific and business knowledge to drive the success of innovations across the fields of life sciences and sustainability. Through our strategy and funding consulting, project management services and more, we deliver impactful expertise throughout the entire innovation journey.

Newsletter

Gain insights and accelerate the growth of your innovations. Sign-up to our monthly newsletter